Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' REDFIELD RR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 51 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Davis, C; Heredia, A; Le, N; Dominique, JK; Redfield, RR
      Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes - Implications for therapy

      JOURNAL OF HUMAN VIROLOGY
    2. Lambert, JS; Redfield, RR; Tramont, EC
      Therapeutic human immunodeficiency virus vaccines: Concept, current status, and future directions

      ANTIRETROVIRAL THERAPY
    3. Birx, DL; Loomis-Price, LD; Aronson, N; Brundage, J; Davis, C; Deyton, L; Garner, R; Gordin, F; Henry, D; Holloway, W; Kerkering, T; Luskin-Hawk, R; McNeil, J; Michael, N; Pierce, PF; Poretz, D; Ratto-Kim, S; Renzullo, P; Ruiz, N; Sitz, K; Smith, G; Tacket, C; Thompson, M; Tramont, E; Yangco, B; Yarrish, R; Redfield, RR
      Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers

      JOURNAL OF INFECTIOUS DISEASES
    4. Cox, JH; Garner, RP; Redfield, RR; Aronson, NE; Davis, C; Ruiz, N; Birx, DL
      Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    5. Ratto-Kim, S; Sitz, KV; Garner, RP; Kim, JH; Davis, C; Aronson, N; Ruiz, N; Tencer, K; Redfield, RR; Birx, DL
      Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: Evaluation of the T cell proliferative response

      JOURNAL OF INFECTIOUS DISEASES
    6. LOOMISPRICE LD; COX JH; MASCOLA JR; VANCOTT TC; MICHAEL NL; FOUTS TR; REDFIELD RR; ROBB ML; WAHREN B; SHEPPARD HW; BIRX DL
      CORRELATION BETWEEN HUMORAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 ENVELOPE AND DISEASE PROGRESSION IN EARLY-STAGE INFECTION

      The Journal of infectious diseases
    7. SITZ KV; LOOMISPRICE LD; KIM SR; KENNER JR; SAU P; ECKELS KH; REDFIELD RR; BIRX DL
      DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING USING V3 LOOP PEPTIDES IDENTIFIES T-LYMPHOCYTE EPITOPES IN HIV-INFECTED INDIVIDUALS

      Journal of allergy and clinical immunology
    8. SITZ KV; LOOMISPRICE LD; RATTOKIM S; KENNER JR; SAU P; ECKELS KH; REDFIELD RR; BIRX DL
      DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING USING 3RD VARIABLE LOOP PEPTIDES IDENTIFIES T-LYMPHOCYTE EPITOPES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS

      The Journal of infectious diseases
    9. LOWELL GH; KAMINSKI RW; VANCOTT TC; SLIKE B; KERSEY K; ZAWOZNIK E; LOOMISPRICE L; SMITH G; REDFIELD RR; AMSELEM S; BIRX DL
      PROTEOSOMES, EMULSOMES, AND CHOLERA-TOXIN-B IMPROVE NASAL IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS GP160 IN MICE - INDUCTION OF SERUM, INTESTINAL, VAGINAL, AND LUNG IGA AND IGG

      The Journal of infectious diseases
    10. KIM JH; LOVELAND JE; SITZ KV; KIM SR; MCLINDEN RJ; TENCER K; DAVIS K; BURKE DS; BOSWELL RN; REDFIELD RR; BIRX DL
      EXPANSION OF RESTRICTED CELLULAR IMMUNE-RESPONSES TO HIV-1 ENVELOPE BY VACCINATION - IL-7 AND IL-12 DIFFERENTIALLY AUGMENT CELLULAR PROLIFERATIVE RESPONSES TO HIV-1

      Clinical and experimental immunology
    11. KIM JH; MCLINDEN RJ; MOSCA JD; BURKE DS; BOSWELL RN; BIRX DL; REDFIELD RR
      TRANSCRIPTIONAL EFFECTS OF SUPERINFECTION IN HIV CHRONICALLY INFECTEDT-CELLS - STUDIES IN DUALLY INFECTED CLONES

      Journal of acquired immune deficiency syndromes and human retrovirology
    12. KIM JH; MCLINDEN RJ; MOSCA JD; VAHEY MT; GREENE WC; REDFIELD RR
      INHIBITION OF HIV REPLICATION BY SENSE AND ANTISENSE REV RESPONSE ELEMENTS IN HIV-BASED RETROVIRAL VECTORS

      Journal of acquired immune deficiency syndromes and human retrovirology
    13. RATTO S; SITZ KV; SCHERER AM; LOOMIS LD; COX JH; REDFIELD RR; BIRX DL
      CD4(-LYMPHOCYTE LINES DEVELOPED FROM HIV-1-SEROPOSITIVE PATIENTS RECOGNIZE DIFFERENT EPITOPES WITHIN THE V3 LOOP() T)

      Journal of acquired immune deficiency syndromes and human retrovirology
    14. MICHAEL NL; DAVIS KE; LOOMISPRICE LD; VANCOTT TC; BURKE DS; REDFIELD RR; BIRX DL
      V3 SEROREACTIVITY AND SEQUENCE VARIATION - TRACKING THE EMERGENCE OF V3 GENOTYPIC VARIATION IN HIV-1-INFECTED PATIENTS

      AIDS
    15. LOOMIS LD; DEAL CD; KERSEY KS; BURKE DS; REDFIELD RR; BIRX DL
      HUMORAL RESPONSES TO LINEAR EPITOPES ON THE HIV-1 ENVELOPE IN SEROPOSITIVE VOLUNTEERS AFTER VACCINE THERAPY WITH RGP160

      Journal of acquired immune deficiency syndromes and human retrovirology
    16. ALLEN PJ; GILLESPIE DL; REDFIELD RR; GOMEZ ER
      LOWER-EXTREMITY LYMPHEDEMA CAUSED BY ACQUIRED IMMUNE-DEFICIENCY SYNDROME-RELATED KAPOSIS-SARCOMA - CASE-REPORT AND REVIEW OF THE LITERATURE

      Journal of vascular surgery
    17. KIM JH; SITZ KV; RATTO S; MCLINDEN RJ; DAVIS K; BURKE DS; BOSWELL RN; MOSCA JD; REDFIELD RR; BIRX DL
      ANTIGEN-INDUCIBLE EXPRESSION OF AN EXOGENOUS IL-7 GENE IN HUMAN, ANTIGEN-SPECIFIC T-CELLS

      Journal of cellular biochemistry
    18. SITZ KV; RATTO S; SCHERER AM; LOOMIS L; REDFIELD RR; BOSWELL RN; BURKE DS; BIRX DL
      GP120 PEPTIDE RECOGNITION BY PBMCS FROM HIV-INFECTED PATIENTS IMMUNIZED WITH EITHER

      Journal of cellular biochemistry
    19. MICHAEL NL; MO T; MERZOUKI A; OSHAUGHNESSY M; OSTER C; BURKE DS; REDFIELD RR; BIRX DL; CASSOL SA
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CELLULAR RNA LOAD AND SPLICING PATTERNS PREDICT DISEASE PROGRESSION IN A LONGITUDINALLY STUDIED COHORT

      Journal of virology
    20. RATTO S; SITZ KV; SCHERER AM; MANCA F; LOOMIS LD; COX JH; REDFIELD RR; BIRX DL
      ESTABLISHMENT AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE-SPECIFIC CD4(-LYMPHOCYTE LINES FROM HIV-1-SEROPOSITIVE PATIENTS() T)

      The Journal of infectious diseases
    21. VANCOTT TC; BETHKE FR; BURKE DS; REDFIELD RR; BIRX DL
      LACK OF INDUCTION OF ANTIBODIES SPECIFIC FOR CONSERVED, DISCONTINUOUSEPITOPES OF HIV-1 ENVELOPE GLYCOPROTEIN BY CANDIDATE AIDS VACCINES

      The Journal of immunology
    22. KIM JH; RATTO S; SITZ KV; MOSCA JD; MCLINDEN RJ; TENCER KL; VAHEY MT; STLOUIS D; BIRX DL; REDFIELD RR
      CONSEQUENCES OF STABLE TRANSDUCTION AND ANTIGEN-INDUCIBLE EXPRESSION OF THE HUMAN INTERLEUKIN-7 GENE ON TETANUS-TOXOID-SPECIFIC T-CELLS

      Human gene therapy
    23. VANCOTT TC; BETHKE FR; KALYANARAMAN V; BURKE DS; REDFIELD RR; BIRX DL
      PREFERENTIAL ANTIBODY RECOGNITION OF STRUCTURALLY DISTINCT HIV-1 GP120 MOLECULES

      Journal of acquired immune deficiency syndromes
    24. BISELLI R; LOOMIS LD; DELBONO V; BURKE DS; REDFIELD RR; BIRX DL
      IMMUNIZATION OF HIV-INFECTED PATIENTS WITH RGP160 - MODULATION OF ANTI-RGP120 ANTIBODY SPECTROTYPE

      Journal of acquired immune deficiency syndromes
    25. VAHEY M; BIRX DL; MICHEAL NL; BURKE DS; REDFIELD RR
      ASSESSMENT OF GAG DNA AND GENOMIC RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN HIV-INFECTED PATIENTS RECEIVING INTERVENTION WITH A RECOMBINANT GP160 SUBUNIT VACCINE IN A PHASE-I STUDY

      AIDS research and human retroviruses
    26. BURNETT PR; POLONIS V; VANCOTT TC; BIRX DL; REDFIELD RR
      IMMUNOGLOBULIN A-MEDIATED NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      AIDS research and human retroviruses
    27. REDFIELD RR; BIRX DL; BRUNDAGE J; ARONSON N; JOHNSON S; KIM J; LENNOX J; MICHAEL N; ROBB M; SITZ K; OSTER C; BURKE DS
      LONG-TERM CLINICAL FOLLOW-UP OF VOLUNTEERS ENROLLED IN AN RGP160 PHASE-1 SAFETY AND IMMUNOGENICITY VACCINE THERAPY TRIAL

      AIDS research and human retroviruses
    28. SITZ KV; VANCOTT TC; DARDEN JM; REDFIELD RR; BIRX DL
      NAIVE AND MEMORY T-LYMPHOCYTES IN THE CONTEXT OF A PHASE-I GP160 VACCINE THERAPY TRIAL

      AIDS research and human retroviruses
    29. REDFIELD RR
      IMMUNE BASED STRATEGIES FOR THE TREATMENT AND PREVENTION OF HIV-INFECTION AND DISEASE

      AIDS research and human retroviruses
    30. RATTO S; SITZ KV; LOOMIS LD; MANCA F; REDFIELD RR; BIRX DL
      EPITOPE MAPPING OF CD4(-LYMPHOCYTE LINES FROM SEROPOSITIVE PATIENTS ENROLLED IN A GP160 VACCINE TRIAL() T)

      Journal of cellular biochemistry
    31. SITZ KV; RATTO S; MANCA F; REDFIELD RR; BIRX DL
      CYTOKINE AND P24 PROFILES IN GP160, GP120, AND TETANUS SPECIFIC T-LYMPHOCYTE LINES FROM HIV-SEROPOSITIVE PATIENTS

      Journal of cellular biochemistry
    32. MICHAEL NL; DARCY L; EHRENBERG PK; REDFIELD RR
      NATURALLY-OCCURRING GENOTYPES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT DISPLAY A WIDE-RANGE OF BASAL AND TAT-INDUCEDTRANSCRIPTIONAL ACTIVITIES

      Journal of virology
    33. MICHAEL NL; VAHEY MT; DARCY L; EHRENBERG PK; MOSCA JD; RAPPAPORT J; REDFIELD RR
      NEGATIVE-STRAND RNA TRANSCRIPTS ARE PRODUCED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED CELLS AND PATIENTS BY A NOVEL PROMOTER DOWN-REGULATED BY TAT

      Journal of virology
    34. VANCOTT TC; BETHKE FR; POLONIS VR; GORNY MK; ZOLLAPAZNER S; REDFIELD RR; BIRX DL
      DISSOCIATION RATE OF ANTIBODY-GP120 BINDING INTERACTIONS IS PREDICTIVE OF V3-MEDIATED NEUTRALIZATION OF HIV-1

      The Journal of immunology
    35. BURNETT PR; VANCOTT TC; POLONIS VR; REDFIELD RR; BIRX DL
      SERUM IGA-MEDIATED NEUTRALIZATION OF HIV TYPE-1

      The Journal of immunology
    36. KIM JH; SITZ KV; RATTO S; MCLINDEN RJ; TENCER K; MOSCA JD; BIRX DL; REDFIELD RR
      CYTOKINE GENE-THERAPY FOR HIV - IMMUNOLOGICAL EFFECTS OF ANTIGEN-INDUCIBLE EXPRESSION OF INTERLEUKIN-7 IN HIV-SPECIFIC AND TETANUS-TOXOID-SPECIFIC T-CELLS

      Clinical research
    37. BIRX DL; REDFIELD RR
      IMMUNOTHERAPEUTIC STRATEGIES IN THE TREATMENT OF HIV-INFECTION AND AIDS

      Current opinion in immunology
    38. LUCEY DR; VANCOTT TC; LOOMIS LD; BETHKE FR; HENDRIX CW; MELCHER GP; REDFIELD RR; BIRX DL
      MEASUREMENT OF CEREBROSPINAL-FLUID ANTIBODY TO THE HIV-1 PRINCIPAL NEUTRALIZING DETERMINANT (V3 LOOP)

      Journal of acquired immune deficiency syndromes
    39. VANCOTT TC; RAUSCH DM; BETHKE FR; KALYANARAMAN VS; LIFSON JD; REDFIELD RR; EIDEN LE
      BINDING INTERACTIONS BETWEEN PEPTIDES CORRESPONDING TO THE CDR3 REGION OF CD4 AND HIV-1 GP120 AS STUDIED BY BIOSPECIFIC INTERACTION ANALYSIS

      Journal of acquired immune deficiency syndromes
    40. LOOMIS LD; MANN F; WAHREN B; REDFIELD RR; BIRX DL
      COMPARING THE HUMORAL RESPONSE IN HIV-1-INFECTED PATIENT VOLUNTEERS POST GP-160 OR GP120 IMMUNIZATION BY PEPSCAN

      Journal of acquired immune deficiency syndromes
    41. POLONIS VR; REDFIELD RR; HOOVENLEWIS C; LIU YL; GARTNER S; REED W
      BIOSYNTHESIS OF HIV-1 ENVELOPE PROTEINS IN NORMAL AND NEOPLASTIC T-CELLS AND MACROPHAGES

      Journal of acquired immune deficiency syndromes
    42. MICHAEL NL; CHANG G; EHRENBERG PK; VAHEY MT; REDFIELD RR
      HIV-1 PROVIRAL GENOTYPES FROM THE PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF AN INFECTED PATIENT ARE DIFFERENTIALLY REPRESENTED IN EXPRESSED SEQUENCES

      Journal of acquired immune deficiency syndromes
    43. KIM JH; MOSCA JD; VAHEY MT; MCLINDEN RJ; BURKE DS; REDFIELD RR
      CONSEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUPERINFECTION OFCHRONICALLY INFECTED-CELLS

      AIDS research and human retroviruses
    44. ROBB M; VAHEY M; WAEKER N; ASCHER D; RUDERMAN J; COOLEY J; MICHAEL N; FISCHER GW; REDFIELD RR
      DEVELOPMENT OF A MARKER FOR HIV VIRAL BURDEN IN PEDIATRIC-PATIENTS USING QUANTITATIVE RNA AND DNA PCR OF PBMC AND PLASMA

      AIDS research and human retroviruses
    45. KIM JH; VAHEY MT; MCLINDEN RJ; MOSCA JD; BURKE DS; REDFIELD RR
      CONSEQUENCES OF HIV-1 SUPERINFECTION OF CHRONICALLY INFECTED-CELLS

      Journal of cellular biochemistry
    46. MICHAEL NL; EHRENBERG PK; DARCY L; VAHEY MT; MOSCA JD; RAPPAPORT J; REDFIELD RR
      NEGATIVE-STRAND TRANSCRIPTS ARE PRODUCED IN HIV-1 INFECTED-CELLS AND PATIENTS BY A NOVEL PROMOTER DOWN-REGULATED BY TAT

      Journal of cellular biochemistry
    47. POLONIS VR; NOVAK JM; MICHAEL NL; GARTNER S; REDFIELD RR
      CELL LINEAGE-SPECIFIC PROCESSING OF HIV-1 NEF - MULTIPLE NEF PROTEIN SPECIES ARE PRODUCED IN MONOCYTE MACROPHAGES

      Journal of cellular biochemistry
    48. ROBB ML; RUDERMAN J; MICHAEL NL; CIESLAK T; REDFIELD RR
      COMPARISON OF HIV ENV SEQUENCE VARIATION FROM UNCULTURED LYMPH-NODE AND SERIAL BLOOD-SAMPLES

      Journal of cellular biochemistry
    49. VANCOTT TC; POLONIS VR; BETHKE FR; JACIR NE; SMITH G; REDFIELD RR; BIRX DL
      CONTRIBUTION OF ANTIBODIES DIRECTED TOWARDS LINEAR AND CONFORMATIONALEPITOPES INDUCED BY MICROGENESIS GP160(LAI) AND GENENTECH GP120(IIIB)VACCINATION OF HIV-1 INFECTED INDIVIDUALS

      Journal of cellular biochemistry
    50. SITZ KV; RATTO S; MANCA F; REDFIELD RR; BIRX DL
      PHENOTYPIC CHANGES DURING THE DEVELOPMENT OF GP160, GP120, AND TETANUS SPECIFIC T-LYMPHOCYTE LINES IN AN HIV SEROPOSITIVE PATIENT

      The Journal of immunology
    51. BIRX DL; LOOMIS L; SITZ KV; VANCOTT T; REDFIELD RR
      RESTRICTED IMMUNE-RESPONSES TO HIV-1 ENVELOPE - ANTIGEN OR HOST

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:28:32